Breaking News
November 21, 2018 - Vitamin D critical to early development of vertebrates, study suggests
November 21, 2018 - Myriad biological, societal factors that impact CKD severity for children of African descent
November 21, 2018 - Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer
November 21, 2018 - Experts offer more clarity on managing common ankle fractures
November 21, 2018 - About 300 million bits of DNA are missing from basic reference genome, report scientists
November 21, 2018 - Study explores how the moving brain processes visual information
November 21, 2018 - Gut protein mutations protect against spikes in blood glucose levels
November 21, 2018 - First probabilistic atlas of thalamus nuclei to better understand the brain
November 21, 2018 - Peanut allergies could soon have a drug treatment
November 21, 2018 - Vanderbilt researchers isolate antibody that can neutralize West Nile virus
November 21, 2018 - KHN’s ‘What the Health?’ Health nerd books for the holidays
November 21, 2018 - MDMA could help gain trust but does not make one naive find researchers
November 21, 2018 - Study uncovers new mechanism controlling the master cancer regulator
November 21, 2018 - Online communication technologies could stave off depression among seniors, shows study
November 21, 2018 - FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis
November 21, 2018 - Artificial intelligence predicts treatment effectiveness
November 21, 2018 - A bicyclist’s road to recovery after traumatic brain injury
November 21, 2018 - New research project to combat obesity, type 2 diabetes receives NIH funding
November 21, 2018 - Humans play key role in distribution and transmission of Bartonella bacteria
November 21, 2018 - First modeling system developed for testing age-specific human immune responses to vaccines
November 21, 2018 - FDA Alert: Gilenya (fingolimod): Drug Safety Communication
November 21, 2018 - Uric Acid Test: MedlinePlus Lab Test Information
November 21, 2018 - Researchers use genetics to predict response to antipsychotic medications
November 21, 2018 - Proposal to include the price of drugs in television ads is flawed, Stanford scholar writes
November 21, 2018 - Disrupting reproduction strategy of disease-causing parasites could help fight malaria
November 20, 2018 - ACAAI: Almost 2 Percent of Children Have Milk Allergy
November 20, 2018 - Congenital anomalies of kidney and urinary tract – Genetics Home Reference
November 20, 2018 - Can video games improve the health of older adults with schizophrenia?
November 20, 2018 - Can flicking a molecular switch restore the aging immune system’s competence?
November 20, 2018 - Restek launches new Oregon cannabis pesticide standards
November 20, 2018 - Health sector coalition urges Government to safeguard patients in future UK-EU relationship
November 20, 2018 - Study evaluates second-hand marijuana smoke exposure among children
November 20, 2018 - Scientists identify three genes responsible for recurrent molar pregnancies
November 20, 2018 - Researchers identify multisystem disorder caused by bi-allelic variants in CCDC47 gene
November 20, 2018 - Dining Out With Allergies Is Tough, But These Steps Can Help
November 20, 2018 - Breastfeeding protects infants from antibiotic-resistant bacteria
November 20, 2018 - AI matched, outperformed radiologists in screening X-rays for certain diseases | News Center
November 20, 2018 - Adolescents increasingly choose marijuana over cigarettes, alcohol
November 20, 2018 - World’s first medical imaging scanner produces diagnostic scan of the whole human body
November 20, 2018 - Cytocybernetics receives NIMH award to move into neuronal drug development
November 20, 2018 - Researchers discover new information on pathological mechanisms of Alzheimer’s disease
November 20, 2018 - ‘Unknown’ enzyme may be key to new treatment for inflammatory diseases
November 20, 2018 - Recreational drug may help people regain trust in others
November 20, 2018 - Researchers identify gene vital for post-stroke recovery
November 20, 2018 - Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury
November 20, 2018 - Potential new therapeutic approach developed for synovial sarcoma
November 20, 2018 - Skeletal imitation reveals how bones grow atom-by-atom
November 20, 2018 - Autism behaviors show unique brain network fingerprints in infants
November 20, 2018 - Location matters for inflammation clearance
November 20, 2018 - Towards finding a druggable cancer target
November 20, 2018 - Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
November 20, 2018 - Cooling ‘brains on fire’ to treat Parkinson’s
November 20, 2018 - Less pollution could increase the average lifespan of Copenhageners by an entire year in 2040
November 20, 2018 - Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network
November 20, 2018 - The plug and play time-resolved spectrometer from PicoQuant
November 20, 2018 - Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration
November 20, 2018 - New report highlights key focus areas to help cancer screening realize its full potential
November 20, 2018 - International experts to discuss strategies to maintain spatial orientation in old age
November 20, 2018 - Low-protein, high-carb diet may promote healthy brain ageing
November 20, 2018 - Scientists discover new inhibitor that decreases lung inflammation
November 20, 2018 - Participation project calls for relaxing research ban on germline interventions
November 20, 2018 - Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
November 20, 2018 - Arthritis by the Numbers: Book of Trusted Facts & Figures
November 20, 2018 - Drug homing method helps rethink Parkinson’s
November 20, 2018 - AHF commends the passage of global AIDS funding in the House, calls for swift approval
November 20, 2018 - The search for new psychiatric disorder treatments
November 20, 2018 - New research offers hope for simpler way to diagnose and treat cancer
November 20, 2018 - Study sheds light on the infection mechanism of influenza virus
November 20, 2018 - Storage failures of eggs and embryos gain a new perspective
November 20, 2018 - Buyers of short-term health plans: Wise or shortsighted?
November 20, 2018 - Study indicates that frogs in virus-exposed groups breed at young age
November 20, 2018 - FDA Alerts Health Care Professionals and Patients Not To Use Sterile Drug Products from Pharm D Solutions
November 20, 2018 - Asthma may contribute to childhood obesity epidemic
November 20, 2018 - Live probiotics can change existing gut flora and alter immune response
November 20, 2018 - Researchers to explore the enigmatic role of unstructured protein in regulating circadian function
November 20, 2018 - Many patients with adenomas do not receive colonoscopy within recommended time frame
November 20, 2018 - Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia
November 20, 2018 - In-person social contact may offer protection against depression and PTSD symptoms
November 20, 2018 - Routine HCV testing in correctional facilities can best identify and treat disease, say researchers
November 20, 2018 - Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors
Breast cancers enlist the help of normal cells to help them spread and survive

Breast cancers enlist the help of normal cells to help them spread and survive

image_pdfDownload PDFimage_print
Breast cancers enlist the help of normal cells to help them spread and survive
Senior author Assistant Professor Alex Swarbrick with co-first authors Dr. Aurelie Cazet and Dr. Mun Hui. Credit: Garvan Institute of Medical Research

Australian researchers have uncovered a secret communication hotline between breast cancers and the normal cells surrounding them. Importantly, the messages sent back and forth between the normal and tumor cells encourage the cancer to survive and to become more aggressive.

Working primarily in mouse models of disease, and also in people (through a Phase I clinical trial), the researchers have shown that triple negative breast tumours—which are the most aggressive and have the fewest treatment options—might one day be treated with a drug that cuts the ‘phone lines’ between normal cells and tumour cells.

The findings, which have just been published in the leading journal Nature Communications, stem from a collaboration between researchers at the Garvan Institute of Medical Research (Sydney), the Centre for Cancer Biology (Adelaide), and GEICAM, Spain’s leading breast cancer research group.

Dr. Aurélie Cazet and Dr. Mun Hui worked with A/Prof Alex Swarbrick (all Garvan) to investigate the role of non-cancerous cells—which, along with cancer cells, are a part of every breast tumour. The researchers analysed the genetic output of thousands of individual cells within the tumour.

Importantly, they found that cancer cells send signals to neighbouring non-cancerous cells (known as cancer-associated fibroblasts or CAFs). And CAFs talk back: they send back their own signals that help the cancer cells become drug-resistant and enter a dangerous state the researchers call ‘stem-like’.

The researchers disrupted the hotline between CAFs and cancer cells by using a drug called SMOi, which targets CAFs and stops them from pushing tumour cells towards a ‘stem-like’ state (see below). In mouse models of triple negative breast cancer, treatment with SMOi reduced the spread of cancer, slowed tumour growth, increased sensitivity to chemotherapy and improved survival.

Following the success in mice, A/Prof Swarbrick worked with GEICAM to carry out a Phase I clinical trial in 12 advanced triple negative breast cancer patients who had relapsed after previously being treated with chemotherapy. Patients were given SMOi together with a standard chemotherapy drug (docetaxel) to determine whether the combination was tolerated by patients.

While the combination treatment did not halt cancer progression in nine patients, disease was stabilised in two patients and tumours fully disappeared in one patient.

“The combination of SMOi plus docetaxel produced a tumour shrinkage in some individuals with triple negative breast cancer, who were not expected to have such responses with docetaxel alone,” says Professor Miguel Martin, Chairman of GEICAM and principal investigator of the trial. “The challenge now is the identification of the molecular characteristics of the patients most likely to respond to the combination.”

“We observed that the trial participants who responded best to the treatment were the ones with evidence of the highest levels of chatter between CAFs and tumour cells,” remarks Dr. Hui. “This is a preliminary finding, but is exciting, because it suggests that it might be possible in the future to identify patients who would respond best to this approach.”

A/Prof Swarbrick, who led the research, says it has led to a major step forward in our understanding of how CAFs can drive aggressive cancer.

“It’s the stem-like cells in breast tumours that are particularly bad players, as they can travel to distant parts of the body to create new tumours and are resistant to treatment,” says A/Prof Swarbrick. “We knew that CAFs played a role in turning cancer cells into a stem-like state, but now we know one way in which they communicate with tumours—and how to stop them talking to one another.”

A/Prof Michael Samuel (Centre for Cancer Biology) worked with A/Prof Swarbrick and Drs Cazet and Hui on the new research.

“We found that when they received signals from cancer cells, CAFs produced large amounts of collagen, a protein that forms a dense scaffold in the tumour, which increased its stiffness and helped to maintain the stem-like state of the cancer cells. When we disrupted the hotline in our models, collagen density was reduced and the cancer cells weren’t as stem-like anymore,” A/Prof Samuel says.

The breadth of this study, from cutting-edge single cell genomics (which explores which genes are turned on and off in thousands of individual cells) through to human clinical trials, has painted a comprehensive picture of how CAFs and tumour cells communicate to drive breast cancer progression and how this knowledge may be used to design more effective treatment.

“Single cell genomics was crucial for this research,” adds Dr. Cazet. “We were able to take a tumour, separate out the cancer cells from the CAFs, and look in detail at the genes that were switched on and off in each cell type. In this way, we were able to uncover their communication strategy, and found the first ever evidence that we may be able to target this communication channel to improve outcomes in triple negative breast cancer.”

Phase I clinical trials in a small number of patients are now complete, and A/Prof Swarbrick and his medical collaborators are currently working on designing and funding Phase II trials to test the effectiveness of this treatment in a larger group of patients. In parallel, A/Prof Swarbrick has plans to investigate prostate cancer, where the same communication may be happening.

“We have preliminary clinical evidence that targeting the hotline between cancer cells and CAFs may be effective in breast cancer,” says A/Prof Swarbrick, “but we certainly hope that this strategy will have applications in other cancer types. We also hope this story will encourage others to look for answers outside the box or rather, outside the tumour cell.”


Explore further:
Researchers discover a potential new therapeutic strategy for pancreatic cancer

More information:
Aurélie S. Cazet et al, Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer, Nature Communications (2018). DOI: 10.1038/s41467-018-05220-6

Journal reference:
Nature Communications

Provided by:
Garvan Institute of Medical Research

Tagged with:

About author

Related Articles